TFF PHARMACEUTICALS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
TFF PHARMACEUTICALS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$5.02 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2023-08-14
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$5.02M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was -$7.05M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-06-30 was -$8.75M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-03-31 was -$8.38M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$31.77M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$31.04M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$18.57M.
- TFF PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2019 was -$11.87M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 2 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 11 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | -$5.02M 10-Q · filed 2023-08-14 | -$12.07M 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$7.05M 10-Q · filed 2023-05-11 | |||||
| 2022-12-31 | -$31.77M 10-K · filed 2023-03-31 | |||||
| 2022-06-30 | -$8.75M 10-Q · filed 2023-08-14 | -$17.12M 10-Q · filed 2023-08-14 | -$27.17M derived: sum of 3 quarters · filed 2023-08-14 | -$35.85M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$8.38M 10-Q · filed 2023-05-11 | -$18.43M derived: sum of 2 quarters · filed 2023-05-11 | -$27.10M derived: sum of 3 quarters · filed 2023-05-11 | -$31.76M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$10.05M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$18.73M derived: sum of 2 quarters · filed 2023-03-31 | -$23.38M derived: sum of 3 quarters · filed 2023-03-31 | -$31.04M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$8.68M 10-Q · filed 2021-11-15 | -$13.33M derived: sum of 2 quarters · filed 2021-11-15 | -$20.99M 10-Q · filed 2021-11-15 | -$26.88M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2021-06-30 | -$4.66M 10-Q · filed 2021-08-12 | -$12.31M 10-Q · filed 2021-08-12 | -$18.21M derived: sum of 3 quarters · filed 2022-05-11 | -$23.26M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2021-03-31 | -$7.65M 10-Q · filed 2022-05-11 | -$13.55M derived: sum of 2 quarters · filed 2022-05-11 | -$18.61M derived: sum of 3 quarters · filed 2022-05-11 | -$22.42M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | -$5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$10.95M derived: sum of 2 quarters · filed 2022-03-24 | -$14.77M derived: sum of 3 quarters · filed 2022-03-24 | -$18.57M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | -$5.06M 10-Q · filed 2021-11-15 | -$8.87M derived: sum of 2 quarters · filed 2021-11-15 | -$12.67M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | -$3.82M 10-Q · filed 2021-08-12 | -$7.61M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | -$3.80M 10-Q · filed 2021-05-13 | |||||
| 2019-12-31 | -$11.87M 10-K · filed 2021-03-10 | |||||
| 2019-09-30 | -$2.84M 10-Q · filed 2020-11-05 | -$5.03M derived: sum of 2 quarters · filed 2020-11-05 | -$7.21M derived: sum of 3 quarters · filed 2020-11-05 | |||
| 2019-06-30 | -$2.19M 10-Q · filed 2020-11-05 | -$4.37M derived: sum of 2 quarters · filed 2020-11-05 | ||||
| 2019-03-31 | -$2.18M 10-Q · filed 2020-11-05 | |||||
| 2018-12-31 | -$3.84M 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | -$585.22K 10-Q · filed 2019-12-09 | -$2.70M derived: sum of 2 quarters · filed 2019-12-09 | ||||
| 2018-06-30 | -$2.12M 10-Q · filed 2019-12-09 | |||||
| 2018-03-31 | -$267.50K 10-Q · filed 2019-12-09 |